🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 18 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2024 28,81 29,22 28,25 28,46 -1,79% 3,37% 906.300
15/03/2024 28,23 29,97 28,23 28,98 +2,22% 6,16% 1.381.200
14/03/2024 29,88 29,94 28,14 28,35 -6,13% 6,03% 1.034.600
13/03/2024 29,90 30,63 29,43 30,20 +1,10% 4,01% 611.500
12/03/2024 30,04 30,57 29,49 29,87 -0,83% 3,60% 462.200
11/03/2024 30,32 30,76 29,78 30,12 -0,66% 3,23% 583.300
08/03/2024 31,41 31,56 30,20 30,32 -1,85% 4,33% 788.000
07/03/2024 31,69 31,86 30,84 30,89 -1,22% 3,23% 847.100
06/03/2024 30,98 31,50 30,53 31,27 +1,00% 3,13% 524.800
05/03/2024 31,60 31,90 30,77 30,96 -2,18% 3,58% 549.100
04/03/2024 32,31 32,74 31,14 31,65 -1,56% 4,95% 514.400
01/03/2024 30,58 33,34 30,25 32,15 +5,83% 10,10% 913.500
29/02/2024 31,00 31,32 30,13 30,38 -0,16% 3,82% 673.500
28/02/2024 30,00 31,40 29,66 30,43 +2,84% 5,80% 605.200
27/02/2024 29,62 29,99 29,33 29,59 +0,20% 2,23% 448.200
26/02/2024 28,41 29,57 28,31 29,53 +3,69% 4,44% 328.800
23/02/2024 27,74 28,56 27,41 28,48 +2,85% 4,15% 289.800
22/02/2024 26,93 27,84 26,93 27,69 +3,40% 3,38% 636.000
21/02/2024 27,17 27,75 26,32 26,78 -1,65% 5,26% 357.900
20/02/2024 27,80 28,47 26,92 27,23 -2,92% 5,58% 518.800
16/02/2024 28,00 28,68 27,87 28,05 -0,64% 2,89% 373.500
15/02/2024 28,11 28,51 27,95 28,23 +1,26% 1,99% 391.200
14/02/2024 27,45 28,24 27,18 27,88 +3,30% 3,86% 490.900
13/02/2024 26,75 27,74 26,25 26,99 -4,60% 5,55% 819.000
12/02/2024 26,79 28,41 26,79 28,29 +5,99% 6,05% 685.600
09/02/2024 26,25 27,29 26,11 26,69 +2,22% 4,50% 610.300
08/02/2024 25,40 26,44 25,26 26,11 +2,75% 4,65% 780.000
07/02/2024 25,70 25,84 25,25 25,41 -1,36% 2,30% 434.100
06/02/2024 25,83 25,92 25,22 25,76 -0,96% 2,71% 942.300
05/02/2024 26,00 26,56 25,63 26,01 -1,81% 3,58% 736.600